Schedule 13D ownership disclosure

Evofem Biosciences Operations, Inc.

Security class unavailable · CUSIP: 30048L104

Event date: 2018-01-17

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
7,037,498
Percent of class
39.6000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000914208-18-000014
Form type
SC 13D
Filer
Evofem Biosciences, Inc.
CIK
CIK 1618835
Filed
Jan 18, 2018
Reporting period
Jan 17, 2018
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub